Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
Phase 4
Active, not recruiting
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 69
- Registration Number
- NCT03092011
- Locations
- 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States
A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's Disease
Phase 4
Terminated
- Conditions
- Parkinson DiseaseParkinsonismFatigue
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 1
- Registration Number
- NCT03034564
- Locations
- 🇺🇸
Cooper University Health System, Camden, New Jersey, United States
An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 20
- Registration Number
- NCT03034538
- Locations
- 🇺🇸
Cooper University Health System, Camden, New Jersey, United States
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
Phase 2
Completed
- Conditions
- Migraine Headache
- Interventions
- Other: ControlOther: Normal saline (1000 mL)
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2019-07-16
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 50
- Registration Number
- NCT02933060
- Locations
- 🇺🇸
Cooper Univeristy Hospital, Camden, New Jersey, United States
Observation for Patients With Asymptomatic CNS Metastatic Disease
Phase 2
Completed
- Conditions
- CancerMetastatic Cancer
- Interventions
- Other: Observation
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2018-05-09
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 33
- Registration Number
- NCT02866981
- Locations
- 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States
Insomnia Interventions in Cancer Survivors
Not Applicable
- Conditions
- Insomnia
- Interventions
- Behavioral: MBSRBehavioral: CBT
- First Posted Date
- 2016-05-26
- Last Posted Date
- 2016-05-26
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 210
- Registration Number
- NCT02783079
- Locations
- 🇺🇸
MD Anderson Cancer Center at Cooper, Voorhees, New Jersey, United States
TIMBER Psychotherapy and Ketamine Single Infusion in Chronic PTSD
Not Applicable
- Conditions
- PTSD
- Interventions
- First Posted Date
- 2016-05-09
- Last Posted Date
- 2016-05-09
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 50
- Registration Number
- NCT02766192
- Locations
- 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
Recruiting
- Conditions
- Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 400
- Registration Number
- NCT02749474
- Locations
- 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States
Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)
Phase 1
Terminated
- Conditions
- Pancreatic CancerPancreatic AdenocarcinomaAdenocarcinoma of the PancreasPancreas AdenocarcinomaPancreas Cancer
- Interventions
- First Posted Date
- 2016-03-14
- Last Posted Date
- 2019-07-30
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 30
- Registration Number
- NCT02707328
- Locations
- 🇺🇸
MD Anderson Cancer Center at Cooper, Camden, New Jersey, United States
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
Early Phase 1
- Conditions
- Pancreatic CancerAdenocarcinoma of the PancreasPancreas AdenocarcinomaPancreas CancerPancreatic Adenocarcinoma
- Interventions
- Radiation: Stereotactic Radiosurgery
- First Posted Date
- 2016-03-14
- Last Posted Date
- 2016-03-14
- Lead Sponsor
- The Cooper Health System
- Target Recruit Count
- 15
- Registration Number
- NCT02707315
- Locations
- 🇺🇸
MD Anderson Cancer Center at Cooper, Camden, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath